TriSalus Life Sciences
TLSI
66 hedge funds and large institutions have $202M invested in TriSalus Life Sciences in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 7 closing their positions.
186% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 7
45% more capital invested
Capital invested by funds: $140M → $202M (+$62.3M)
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
25% more funds holding
Funds holding: 53 → 66 (+13)
23.85% more ownership
Funds ownership: 57.62% → 81.46% (+24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$17.1M |
| 2 |
HP
Hartree Partners
New York
|
+$16.9M |
| 3 |
DM
Deerfield Management
New York
|
+$9.79M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$6.94M |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$6.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$12.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.01M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$2.76M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.61M |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$2.42M |
TLSI Hedge Fund Activity: Q3 2021 in Review
66 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q3 2021, worth a combined $202M — up 45% from $140M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new TLSI positions and 7 closed out — a net gain of 13 holders — while 14 added to existing stakes and 11 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $17.1M. The largest seller was Park West Asset Management, exiting entirely with an estimated $12.1M sold.
- 66 institutional investors held TriSalus Life Sciences (TLSI) as of Q3 2021, up from 53 in Q2 2021.
- Funds reported $202M of TriSalus Life Sciences stock for Q3 2021, up 45% quarter-over-quarter.
- 20 funds opened new TriSalus Life Sciences positions in Q3 2021 and 7 closed out, a net change of +13 holders.
- The largest TriSalus Life Sciences buyer in Q3 2021 was Magnetar Financial, an estimated $17.1M added.
- The largest TriSalus Life Sciences seller in Q3 2021 was Park West Asset Management, an estimated $12.1M sold.
Based on aggregated 13F filings for Q3 2021.